China's Health Minister Chen Zhu receives his second
inoculation of the country's A/H1N1 flu vaccine. Chen received the first
shot in China on July 22.(Photo Source: moh.gov.cn)
¡¡BEIJING, Aug. 12 (Xinhua) -- China's Health Ministry announced
Wednesday initial clinical tests on the country's A/H1N1 flu vaccines proved the
drug to be "safe and reliable" for human use, as test volunteers readied
themselves for a second round of inoculation.
No cases of severe adverse drug reactions had been
reported among more than 13,300 volunteers who took part in clinical trials of
vaccines developed by 10 Chinese pharmaceutical companies, said a statement from
In a demonstration of confidence in the drugs, Health
Minister Chen Zhu took the lead Wednesday afternoon by receiving his second
inoculation of the vaccine. Chen received the first such shot in China on July
The other volunteers will receive their second
vaccinations from later Wednesday, 21 days after their first shot.
They would be studied by an expert team from the
Health Ministry and further results will be compiled in mid August, said Wang
Yu, director of the Chinese Center for Disease Control and Prevention (CCDCP).
All clinical trials of China's vaccines were
supervised by the CCDCP.
Wang said the ministry would unveil China's
vaccination plan after the A/H1N1 flu vaccine clinical trials end in mid
September, adding that safety was the top priority in the research and
development of the drug.
By August 10, the Chinese mainland had confirmed
2,348 cases of A/H1N1 influenza, with no fatal cases, of those, 2,167 people
In another circular Wednesday, the ministry called
for stepped-up flu monitoring nationwide in order "to keep a timely watch on the
spread and the mutation of the virus."
The ministry decided in May to increase the numbers
of hospitals and laboratories to monitor seasonal flu respectively from 197 and
84 to 556 and 411. They have been told to begin flu monitoring from August 15
and August 30 respectively.
World Tackles A/H1N1